Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthopediatrics (KIDS) Interest Expenses (2016 - 2026)

Orthopediatrics has reported Interest Expenses over the past 7 years, most recently at $2.1 million for Q1 2026.

  • For Q1 2026, Interest Expenses rose 86.68% year-over-year to $2.1 million; the TTM value through Mar 2026 reached $7.0 million, up 124.18%, while the annual FY2025 figure was $6.0 million, 128.77% up from the prior year.
  • Interest Expenses for Q1 2026 was $2.1 million at Orthopediatrics, up from $1.9 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.1 million in Q1 2026 and troughed at -$303000.0 in Q4 2023.
  • A 4-year average of $894250.0 and a median of $876500.0 in 2024 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 1823.81% in 2024 and fell as far as 11.22% in 2024.
  • Year by year, Interest Expenses stood at -$303000.0 in 2023, then surged by 535.31% to $1.3 million in 2024, then surged by 46.47% to $1.9 million in 2025, then rose by 8.8% to $2.1 million in 2026.
  • Business Quant data shows Interest Expenses for KIDS at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $1.8 million in Q3 2025.